Stock Movers: CVS Rises on Profit Forecast, PepsiCo Drops Amid Restructuring, Ares Joins S&P 500

CVS Navigates Turbulent Retail Environment

• 📈 CVS shares are up approximately 3% following a raised full-year profit forecast and an expectation of earnings growth in 2026.
• 💰 The company projects adjusted earnings of up to $7.20, exceeding street expectations, and anticipates a profit of about $6.60 for the current year, a 5-cent increase from its previous guidance.
• 💡 Despite facing government scrutiny in healthcare and changing practices by drug benefit managers, CVS is demonstrating a strong turnaround, with its stock up over 70% year-to-date under a new CEO.

PepsiCo's Restructuring and Market Challenges

• 📉 PepsiCo (PEP) stock has declined about 1% due to an agreement with activist investor Elliott Investment Management.
• 🥤 Key changes include a 20% reduction in its US product lineup, lower prices, and workforce adjustments.
• ⚠️ The company faces multiple headwinds, including softening consumer demand, rising costs, and tariffs, which are impacting investor confidence.
• 🌱 Despite efforts to pivot towards healthier options like fiber and protein drinks, PepsiCo's stock has struggled this year.

Ares Management Joins the S&P 500

• 🚀 Ares Management (ARES) experienced a significant surge, climbing as much as 9.4%, after being selected to join the S&P 500 index.
• 🧩 The company will replace Kellanova in the S&P 500, effective December 11th.
• 📊 Analysts from Bloomberg Intelligence suggest Ares's inclusion will boost passive ownership in the stock to the high teens, a key factor exciting investors.
• 🌟 With a market capitalization of $54 billion, Ares is one of the larger companies not previously included in the S&P 500, highlighting its significant market presence.